Mucosal-associated invariant T cells promote atherosclerosis through monocyte-driven inflammation
Cardiovascular Research · 07.11.2026
DOI: 10.1093/cvr/cvag274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 07.11.2026. Verfasst von Tobias Radecke und 31 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Inserm, PARCC, F-75015 Paris, France.
Abstract (Originalsprache)
Aims
Mucosal-associated invariant T (MAIT) cells are innate-like T lymphocytes involved in antimicrobial defence and inflammatory regulation, yet their contribution to atherosclerosis remains poorly defined. This study aimed to characterize the distribution, phenotype, and functional role of MAIT cells in human atherosclerotic lesions and complementary murine models. Methods and Results MAIT cells were identified using MHC class I-related protein 1 (MR1) tetramers loaded with the agonist 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU). They were significantly enriched among CD3+ T cells in human carotid atherosclerotic plaques compared with matched peripheral blood. Plaque-resident MAIT cells displayed an activated, exhaustion-prone phenotype and a distinct transcriptional profile characterized by upregulation of inflammatory, stress-response, and chemotactic pathways, as revealed by bulk RNA sequencing of purified cells. In murine models, low-density lipoprotein receptor-deficient (Ldlr−/−) mice carrying the CAST locus, which confers increased MAIT cell frequency, exhibited enhanced MAIT cell accumulation in the liver and aorta under a high-cholesterol diet. We identified mature MAIT in the bone marrow which displayed activated state. Moreover, Bulk RNA sequencing of bone marrow-sorted MAIT cells from these mice revealed transcriptional signatures consistent with immune activation and enhanced myelopoiesis. In contrast, MAIT cell-deficient Ldlr−/−CAST MR1−/− mice showed reduced atherosclerotic burden, decreased liver fibrosis, and smaller myocardial infarcts following coronary artery ligation, without changes in plasma cholesterol levels. These protective effects were associated with reduced myeloid progenitors and bone marrow and circulating monocytes, as well as decreased macrophage accumulation within plaques. Importantly, disruption of monocyte mobilization via CCR2 deficiency abrogated MAIT cell–dependent effects, demonstrating a monocyte-mediated mechanism.
Conclusions
MAIT cells accumulate in human atherosclerotic plaques and acquire a pro-inflammatory, functionally altered phenotype. Experimental evidence demonstrates that MAIT cells promote atherosclerosis and its complications by enhancing myelopoiesis and monocyte-driven vascular inflammation. These findings identify MAIT cells as previously unrecognized regulators of monocytosis and highlight their potential as therapeutic targets in atherosclerotic cardiovascular disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Paris Cité, Inserm, PARCC, F-75015 Paris, France.
- Cardiovascular division, Hôpital européen Georges-Pompidou APHP, Paris, France.
- Clinique Saint Gatien Alliance (NCT+), 37540 Saint-Cyr-sur-Loire, France.
- Institut Necker-Enfants Malades (INEM), Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, 75015 Paris, France.
- Université Paris Cité, INSERM, U1149, CNRS, ERL 8252, Centre de Recherche sur l'Inflammation (CRI), Paris, France.
- Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.
ORCID-Profile: Louise Z Wang, Nirmala Mouttoulingam, Paul Alayrac, Ludivine Laurans, Pierre Liénart, Salma El Batti, Franck Letourneur, Hafid Ait-Oufella, Tristan Mirault, Ziad Mallat, Soraya Taleb
Zitieren
APA
Radecke, T., Nipoti, T., Wang, L. Z., Mouttoulingam, N., Diedisheim, M., Chajadine, M., Bacquer, E., Heron, C., Alayrac, P., Caër, C., Laurans, L., Knosp, C., Liénart, P., Damache, K., Al-Rifai, R., Camus, S., Lemitre, M., Piollet, M., Soehnlein, O., …, & Taleb, S. (2026). Mucosal-associated invariant T cells promote atherosclerosis through monocyte-driven inflammation. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag274
Vancouver
Radecke T, Nipoti T, Wang LZ, Mouttoulingam N, Diedisheim M, Chajadine M, et al. Mucosal-associated invariant T cells promote atherosclerosis through monocyte-driven inflammation. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag274
BibTeX
@article{Radecke2026,
author = {Radecke, Tobias and Nipoti, Thomas and Wang, Louise Z and Mouttoulingam, Nirmala and Diedisheim, Marc and Chajadine, Mouna and Bacquer, Emilie and Heron, Coraline and Alayrac, Paul and Caër, Charles and Laurans, Ludivine and Knosp, Camille and Liénart, Pierre and Damache, Kenza and Al-Rifai, Rida and Camus, Stephane and Lemitre, Mathilde and Piollet, Marie and Soehnlein, Oliver and Julia, Pierre and Alsac, Jean-Marc and El Batti, Salma and Letourneur, Franck and Cochain, Clément and Tedgui, Alain and Ait-Oufella, Hafid and Mirault, Tristan and Mallat, Ziad and Lantz, Olivier and Silvestre, Jean-Sebastien and Lotersztajn, Sophie and Taleb, Soraya},
title = {Mucosal-associated invariant T cells promote atherosclerosis through monocyte-driven inflammation},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvag274}
}
EUVIMED